CODX PDUFA decision: a positive outcome, +5.8%

On January 7, 2026, Co-Diagnostics, Inc. reached its PDUFA decision. The result was a positive outcome, and the stock moved +5.8% in the window around the event. It had already run -46.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.